News
5d
WKBN Youngstown on MSNHubbard senior wins with PSA for breast cancerHubbard High School student Mia King won the Tom Holden Memorial Scholarship contest with her PSA entry showcasing the ...
5d
News-Medical.Net on MSNResearchers link 9 blood proteins to breast cancer and suggest 3 drugs for repurposingResearchers used integrated Mendelian randomization in a cohort of over 247,000 individuals to identify 62 plasma proteins associated with breast cancer risk. Nine high-confidence targets, including ...
Explore how nanosensors are transforming cancer diagnostics by enabling earlier, more accurate, and less invasive detection ...
Study data from 42,135 breast cancer survivors were pooled using statistical modelling to assess the relationship between an unhealthy metabolic profile and survival of breast cancer. The pooled ...
Experts are warning against overusing these common cooking oils because they contain a fat that is reportedly linked to breast cancer. Seed and vegetable oils don’t have the best reputation ...
Breast Cancer Journeys: Women’s Stories opened April 4 at the First Congregational United Church of Christ’s gallery in ...
Median overall survival of 17.3 months in Bria-IMT™ treated patients with hormone receptor positive (HR+) metastatic breast cancer markedly exceeds historical data of 14.4 months in TRODELVY ...
Olivia Williams opened up about her harrowing journey with pancreatic cancer, revealing she experienced years of misdiagnoses and dismissals by doctors. The professionally trained British actress ...
Being obese makes breast cancer survivors up to 80 per cent more likely to die from the disease, alarming research has suggested. Danish researchers found women with collection of weight-related ...
In Europe, approximately 531,000 breast cancer patients are diagnosed annually, with around 141,000 deaths, and around half of all cases would fall under the HER2-low classification, split between ...
Roche revealed in its first-quarter results statement that giredestrant missed the mark in the phase 2 acelERA trial in advanced breast cancer, in what appears to be another blow to the emerging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results